Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes-Reference-Cited by-同舟云学术

Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes

Published:2007-07 Issue:1 Volume:77 Page:58-61
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Zhang Huijuan,Liu Xiaomin,Kuang Hongyu,Yi Ran,Xing Houxun

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference17 articles.

1. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1;Huopio;Lancet,2003

2. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus;Szoke;Compr. Ther.,2005

3. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene;Hansen;Diabetes,1998

4. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin;Rissanen;Diabetes Care,2000

5. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects;Zychma;Med. Sci. Monit.,2002

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing anti oxidant, antidiabetic potential and GCMS profiling of ethanolic root bark extract of Zanthoxylum rhetsa (Roxb.) DC: Supported by in vitro, in vivo and in silico molecular modeling;PLOS ONE;2024-08-19

2. Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia;The Journal of Clinical Endocrinology & Metabolism;2024-01-24

3. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

4. Combination low dose sulphonylurea and DPP4 inhibitor have potent glucose lowering effect through augmentation of beta cell function without increase in hypoglycaemia: a randomised crossover study;2023-08-24

5. Precision Medicine in Diabetes, Current Research and Future Perspectives;Journal of Personalized Medicine;2022-07-28